Trial Information
Steroid Induced Osteoporosis in the Pediatric Population Ancillary Study- Osteonecrosis in Children With Acute Lymphoblastic Leukemia
Inclusion Criteria:
- Enrollment in the STOPP-CIS study
- Informed consent of patient or care givers
- >5 years of age at MRI assessment
Exclusion Criteria:
- Individuals with a history of claustrophobia precluding MRI assessment
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
osteonecrosis 1 year post leukemia therapy
Outcome Description:
Each participant will undergo MRI of hip, knee, ankle and shoulder to look for ON
Outcome Time Frame:
One year after completion of therapy for leukemia
Safety Issue:
No
Principal Investigator
Jacqueline Halton
Investigator Role:
Principal Investigator
Investigator Affiliation:
Childrens Hospital of Easten Ontario
Authority:
Canada: CHEO Research Ethics Board
Study ID:
08/20E
NCT ID:
NCT01104324
Start Date:
July 2009
Completion Date:
December 2012
Related Keywords:
- Osteonecrosis
- Acute Lymphoblastic Leukemia
- bone health
- Osteonecrosis
- acute lymphoblastic leukemia
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Osteonecrosis